Event Date & TimeClick the calendar icon to add events
to your Personal Calendar

  • Sep 13, 2018 - Sep 14, 20188:00 am - 4:30 pm


College of Physicians and Surgeons of Manitoba

1000 – 1661 Portage Avenue, Winnipeg, Manitoba, Canada, R3J 3T7

Click to Log In Create an Account

* You must be logged in to purchase event tickets.

Course Objectives:

At the end of this workshop, participants will be able to:

Have the prerequisite knowledge for initiating and monitoring patients on methadone and/or buprenorphine/naloxone.
Have developed basic decision making skills essential to providing or dispensing safe and effective opioid replacement therapy.
Appreciate the value of sensitivity, understanding and commitment in the delivery of addictions medicine in clinical or pharmacy practice.

Specific Learning Objectives:

By completing the assigned pre-reading and participating in this workshop, learners will, through interactive, multidisciplinary learning activities (including power point presentations with discussion, small group simulated patient interviews and case discussions and reflective exercises) achieve the following objectives:

  • Review opioid use disorder (neuroanatomy and pathophysiology of the brain’s reward system, typical clinical presentations, typical behaviours, DSM-5 criteria).
  • Review the model of addiction as a chronic disease, requiring long term management by health care professional(s) as well as mental health, spiritual and social support.
  • Perform a comprehensive assessment of an individual with opioid use disorder and select appropriate treatment options.
  • Understand the unique pharmacology of methadone and buprenorphine/naloxone and participate effectively in prescriber – pharmacist collaborative care.
  • Identify potential and actual drug interactions.
  • Select an appropriate methadone induction dose and manage initial methadone induction, dose adjustments and early stabilization issues appropriately.
  • Understand how to assess a patient’s appropriateness for carry doses, including frequent reassessment and as-needed adjustments to carry status.
  • Understand important issues in the maintenance phase of treatment, including urine toxicology, prolonged QT, split dosing, smoking cessation support and withdrawal of treatment.
  • Understand special considerations in the treatment of pregnant women with opioid use disorder – in the ante-natal period, during labour and post- partum, including breast feeding.
  • Review neonatal opioid withdrawal and understand how treatment decisions may impact withdrawal severity and overall maternal/neonatal outcomes.
  • Understand the role education and advocacy plays in promoting improved neonatal/maternal outcomes and strengthening the family unit.
  • Understand special issues in the management of individuals with opioid use disorder and concurrent major psychiatric disorders.
  • Understand special issues in the management of individuals with opioid use disorder and concurrent true chronic pain.
  • Understand special considerations in the management of the individual with opioid use disorder and hepatitis C and/or HIV.
  • Develop a practical approach to managing insomnia in the patient with opioid use disorder.
  • Understand important safety considerations and develop a practical approach to managing individuals with opioid use disorder who also abuse alcohol and/or benzodiazepines.
  • Understand different models of service delivery in opioid replacement therapy including the comprehensive care model, private clinic model, community clinic model and family practice model. Understand the strengths and weaknesses of each model.
  • Integrate and ensure safe preparation, documentation, and dispensing of methadone in pharmacy practice.

Day 1 Agenda September 13:

  • 8:00 – 8:30 Check In and Coffee

  • 8:30 – 8:45 Introductions and Orientation to the Workshop (Includes pre-test)

    8:45 – 09:30  A Review of Opioid use disorder and emerging inpatient and community disease patterns…..Ginette Poulin

    09:30 – 10:15 Treatment approaches – the evidence and how it informs local practice (includes discussion on abstinence vs. harm reduction, naloxone and psychosocial support groups)…..Erin Knight

  • 10:15 – 10:30 Coffee Break (provided)

  • 10:30 – 11:00 Now what? Includes things to consider starting out in ORT practice, who’s doing what out there and the exemption process…..Marina Reinecke

    11:00 – 12:00 Pharmacology of methadone and buprenorphine/naloxone and prescriber – pharmacist collaborative care…..Nicole Nakatsu

  • 12:00 – 12:30 Lunch (provided)

  • 12:30 – 13:15 The comprehensive patient assessment  Talia Weisz

    13:15 – 14:15 From Initiation to the Maintenance phase – Dose adjustments, Urine toxicology, Carries, Split dosing, Management of concurrent alcohol; benzodiazepine; OTC medication use, Insomnia…..Erin Knight

  • 14:15 – 14:30 Coffee Break (provided)

  • 14:30 – 15:30 (Pharmacists) Break-out session # 1 – Integrating methadone and buprenorphine/naloxone into pharmacy practice – Part 1: An overview…..Mike Sloan

    Prescribers Standardized patient (Talia & Nicole) interviews -2 groups (Ginette & Erin facilitates)

    15:30 – 16:25 (Prescribers and Pharmacists) Break-out session # 2: Case discussions – Erin, Marina, Nicole & Mike facilitates

  • 16:25 – 16:30 Day 1 Evaluation forms

Day 2 Agenda September 14:

  • 8:00 – 8:30  Check In and Coffee

  • 8:30 – 8:45  Reflections from day 1 and Lindy’s tool

    8:45 – 9:30:  Withdrawal of Treatment…..Marina Reinecke

    9:30 – 10:15   Special Considerations: HIV and Hep C in the context of Opioid Replacement Therapy…..Laurie Ireland

  • 10:15 – 10:30  Coffee Break (provided)

  • 10:30 – 11:30  Special Considerations: Pregnancy….Marina Reinecke

    11:30 – 12:30   (Prescribers) Special considerations: Opioid Replacement with Comorbid Mental Illness – Benefits and Risks…..James Simm

    11:30 – 12:30  (Pharmacists) Break-out session # 3 – Integrating methadone and buprenorphine/naloxone into pharmacy practice – Part 1 continued: Witnessed ingestion…..Mike Sloan

  • 12:30 – 13:00  Lunch (provided)

  • 13:00 – 14:00  Special Considerations: Acute and chronic pain in the context of opioid replacement therapy…..Kulvir Badesha

    14:00 – 15:00  (Pharmacists) Break-out session # 4: Integrating methadone and buprenorphine/naloxone into pharmacy practice – Part 2: Special situations…..Mike Sloan

    Prescribers:  Standardized patient (Talia & Nicole) interviews -2 groups (Ginette & Marina facilitates)

  • 15:00 – 15:15  Coffee Break (provided)

  • 15:15 – 16:15  (Prescribers and Pharmacists) Break-out session # 5: Case discussions – Marina, Nicole & Mike facilitates

  • 16:15 – 16:30  Wrap-up, Day 2 and Overall Evaluation Forms, Post-test

Prior to attending this workshop participants are required to complete the following prerequisite readings listed below:

Methadone Maintenance Treatment: Client Handbook REVISED; Can be found at:

The College of Physicians and Surgeons of Manitoba’s publication: “Manitoba Methadone & Buprenorphine Maintenance: Recommended Practice”. Can be found at:

The College of Pharmacists of Manitoba guidelines: “Principles for the Provision of Opioid Dependence Treatment by Manitoba Pharmacists (required reading for pharmacists only); Can be found at:

General Inquiries or questions regarding the workshop can be directed to your Regulatory Body:

Marina Reinecke MBChB, CCFP (ISAM Certified), Medical consultant, CPSM
marina.reinecke@umanitoba.ca or 204 294 2162

Diana Heywood RN MN, Practice and Standards Consultant, CRNM
dheywood@crnm.mb.ca or 204 784 6467

Kim McIntosh, B.Sc.(Pharm), Assistant Registrar – Qualifications and Practice Development, CPhM
kmcintosh@cphm.ca or 204-233-1411 ext 230

Click to Log In Create an Account

* You must be logged in to purchase event tickets.


Program Coordinator

  • missing-profile
    Lenore Chipman

    Program Coordinator, CPD - Medicine
    Office of Continuing Competency and Assessment
    Rady Faculty of Health Sciences
    University of Manitoba
    Tel: 204-789-3238
    Fax: 204-789-3911
    Email: Lenore.Chipman@umanitoba.ca